$ESAB

ESAB (ESAB) Q2 2026 Earnings Call Transcript

ESAB (ESAB) reported Q2 2026 core sales of $766 million, up 13% year over year, with 2.5% core organic growth. Adjusted EBITDA was $150 million, up 8%, and margin was 19.5%. Full-year guidance: core sales $3.0-$3.1B, adjusted EBITDA $615-$625M, adjusted EPS $5.40-$5.50, including Eddyfi. Middle East sales fell 10%-11% amid conflict.

Original reporting
Published Aug 13, 2026, 1:45 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 13, 2026, 2:14 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
ESAB (ESAB) Q2 2026 Earnings Call Transcript — source image
Decision brief

The 30-second read

$ESABBullishMed
01

Why it matters

Traders can update models using the newly stated full-year core sales, adjusted EBITDA, and adjusted EPS ranges, along with Eddyfi’s margin profile and disclosed headwinds (Middle East logistics and transitory neutrality).

02

Market read

Fresh FY guidance and acquisition integration metrics (Eddyfi margins, funnel size, and specific headwinds) are likely to drive near-term estimate revisions and positioning.

03

What to watch

Eddyfi’s contribution is framed as seven months in FY guidance, so investors may need to watch for integration execution risk and whether the $450M funnel converts into revenue on the expected timeline.

Relevance 8/10Novelty 8/10Timing: ahead of next earnings cycle, guidance update from the Q2 2026 call

Background

ESAB’s Q2 2026 earnings call centers on portfolio transformation toward equipment and gas control, plus the Eddyfi acquisition integration.

Company-level read

Ticker impact

$ESABBullishMedium confidence
Context

ESAB guided full-year core sales to $3.0B-$3.1B and adjusted EPS to $5.40-$5.50, incorporating seven months of Eddyfi.

Expected impact

Moderately positive bias, with upside contingent on Eddyfi integration and continued equipment mix shift.

Evidence & confidence

Management disclosed updated full-year guidance ranges, Eddyfi’s margin profile, and specific headwinds (logistics drag, price/cost neutrality) plus a $1B bond prefunding plan, which are direct inputs to valuation and near-term expectations.

Market effects

Supports the broader welding and industrial automation theme that inspection and monitoring tech can lift margins via higher-value workflow solutions.

Highlights Middle East conflict as a measurable demand and logistics headwind (7%-8% of business) that could affect regional industrial equipment sentiment.

Reinforces cross-border industrial capex demand resilience in Americas and EMEA/Asia, with growth increasingly tied to equipment and automation rather than purely consumables.

Counterpoint

Guidance includes transitory price/cost neutrality drag and logistics cost inflation; if these persist, margin and EPS could undershoot despite the equipment mix story.

Key entities

  • ESAB

    Welding and industrial solutions company reporting Q2 2026 results and updated full-year guidance, including Eddyfi acquisition contribution.

  • Eddyfi

    Inspection and monitoring technologies business acquired by ESAB, with disclosed gross and EBITDA margin profile and a $450M commercial opportunity funnel.

  • Shyam Kambeyanda

    CEO who characterized Eddyfi as a defining step for faster organic growth and higher margins.

  • Brent Jones

    CFO who discussed guidance updates and the $1B bond offering used to prefund the Eddyfi acquisition.

Related articles

$INFYMed

Aug 12: Markets Extend Losses as Tata Stocks, IT Shares Drag; Nifty Slips Below 24,450 – The Indian Awaaz

Indian benchmarks extended losses. The Nifty 50 fell 35.75 points, or 0.15%, to 24,435.95, and the Sensex dropped 187.90 points, or 0.24%, to 77,966.35. Tata stocks and IT shares weighed after Tata Sons chairman N Chandrasekaran said he will not seek reappointment. TCS fell 3.93% and Infosys 1.23%. India CPI inflation rose to 4.45% in July, from 4.38% in June.

$ESABMedAI 8/10

ESAB Q2 Deep Dive: Equipment Strength and Eddyfi Integration Drive Strategic Shift

ESAB reported Q2 revenue of $807.6 million, above analysts’ $787.2 million, with adjusted EPS of $1.33 versus $1.37 expected. Adjusted EBITDA was $151.4 million, slightly above estimates. Full-year adjusted EPS guidance of $5.45 and EBITDA guidance of $620 million both missed. Management cited equipment and automation strength and Eddyfi integration, while Middle East revenue fell due to geopolitical disruption and higher logistics costs.

$ESABMedAI 8/10

ESAB Q2 Earnings Call Highlights

ESAB (NYSE:ESAB) discussed its Q2 earnings call and Eddyfi integration. Management said Eddyfi has high-single-digit growth, ~65% gross margins and ~30% EBITDA margins, with a ~$450 million commercial funnel. ESAB raised FY2026 outlook to core sales of ~$3.0-3.1B, adjusted EPS $5.40-5.50, and adjusted EBITDA $615-625M.

$ESABMed

ESAB’s (NYSE:ESAB) Q2 CY2026 Sales Beat Estimates

ESAB (NYSE:ESAB) reported Q2 CY2026 revenue of $807.6 million, up 12.9% year over year, exceeding Wall Street estimates by 2.6%. Non-GAAP EPS was $1.33, down from $1.36 a year earlier and 3% below consensus. Operating margin fell to 9.7% from the prior year. Analysts expect full-year EPS to rise from $5.31 to $6.08.

$ESABHigh

ESAB Corp (ESAB): Results of Operations and Financial Condition

ESAB Corp (ESAB) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 q22026earningspressrelease.htm EX-99.1 Document ESAB Corporation Announces Second Quarter 2026 Results • Record total sales increased 12.9%, with core organic sales up 2.5% • Core organic growth in both segments • Closed Eddyfi ahead of schedule • Updating 2026 outlook

$ESABMed

Q4 Results 29th May Live: Asian Paints, IndiGo, NMDC, Glenmark Pharma, Ipca Lab, IREDA, Gujarat Gas, Natco Pharma, Inox Wind, Rubicon Research, BEML, NMDC Steel, JM Financial, Triveni Engg to announce

The article previews Q4 results from multiple Indian companies and highlights several earnings updates. Prime Focus reported standalone net profit of Rs 4.32 crore for March 2026 quarter vs Rs 16.11 crore loss a year earlier. Alkem Laboratories’ standalone net profit fell to Rs 217 crore from Rs 276.9 crore; it recommended a final dividend of Rs 10/share. It also cites Q4FY26 figures for ESAB India, Ecos Mobility, and Ivalue Infosolutions, plus early stock moves.